Clinical Trials List
2024-09-01 - 2038-12-31
Phase III
Recruiting9
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 廖偉志 Division of Thoracic Medicine
- Chen Chia-Hung Division of Thoracic Medicine
- 方信元 Division of Thoracic Surgery
- 郭育筑 Division of Thoracic Medicine
- Wen-Chien Cheng Division of Thoracic Medicine
- 陳旆聿 Division of Others
- 陳昫元 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃得瑞 Division of Hematology & Oncology
- YEN-TING LIN Division of General Internal Medicine
- 莊仁豪 Division of General Surgery
- Chia-Chi Lin Division of Hematology & Oncology
- WEI-LI MA Division of Hematology & Oncology
- JIN-SHING CHEN Division of General Surgery
- SHUENN-WEN KUO Division of General Surgery
- 林宗哲 Division of Hematology & Oncology
- JIN-YUAN SHIH Division of General Internal Medicine
- 蔡東明 Division of General Surgery
- 廖斌志 Division of Hematology & Oncology
- 吳尚俊 Division of General Internal Medicine
- Hsao-Hsun Hsu Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chih-Liang Wang Division of Hematology & Oncology
- 柯皓文 Division of Hematology & Oncology
- 邱立忠 Division of Thoracic Medicine
- Chih-Hsi Kuo Division of Hematology & Oncology
- 黃宗楨 Division of Hematology & Oncology
- Chao Yin-Kai Division of Thoracic Surgery
- Cheng-Ta Yang Division of Hematology & Oncology
- Chih-Hung Chen Division of Hematology & Oncology
- 枋岳甫 Division of Infectious Disease
- Chien-Ying Liu Division of Hematology & Oncology
- Jia-Shiuan Ju Division of Hematology & Oncology
- 陳維勳 Division of Thoracic Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shang-Yin Wu Division of Hematology & Oncology
- Chin-Wei Kuo Division of General Internal Medicine
- 黃維立 Division of General Surgery
- Wu-Chou Su Division of Hematology & Oncology
- Chun-Hui Lee Division of Hematology & Oncology
- Chian-Wei Chen Division of General Internal Medicine
- Seu-Chun Yang Division of General Internal Medicine
- 張超群 Division of General Surgery
- Yau-Lin Tseng Division of Thoracic Surgery
- Yi-Ting Yen Division of General Surgery
- 林建佑 Division of General Internal Medicine
- 陳盈元 Division of General Surgery
- 蔡政軒 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- YEN-HAN TSENG 無
- Yuh-Min Chen 無
- 徐博奎
- 廖映庭 Division of Hematology & Oncology
- Yi-Chen Yeh
- 趙恒勝 無
- Chi-Lu Chiang 無
- 蕭慈慧 無
- Hsu-ching Huang
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
680 participants
